Molecular Markers of Prognosis in Colorectal Cancer Patients

N/ACompletedNCT00220142

Royal Marsden NHS Foundation Trust103 enrolled

Overview

To correlate the molecular profile of a series of defined CRCs with prognosis and toxicity.

Study Type

OBSERVATIONAL

Enrollment

103

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * All patients participating in the RMHNHST study of infusional versus bolus 5FU (Saini et al. 2003).

Royal Marsden Hospital

Sutton, Surrey, United Kingdom

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.